Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 2/20 | 0.48 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.48 |
| ▸ | SMYD3 | Q9H7B4 | 8/20 | 0.46 |
| ▸ | GNAI3 | P08754 | 4/20 | 0.46 |
| ▸ | GNAO1 | P09471 | 4/20 | 0.46 |
| ▸ | GNAI1 | P63096 | 4/20 | 0.46 |
| ▸ | NAMPT | P43490 | 1/20 | 0.42 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.41 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.41 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.40 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.40 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.40 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | SLC6A12 | P48065 | 1/20 | 0.39 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.39 |
| ▸ | SLC6A13 | Q9NSD5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11496439 | 0.87 | DDB1 (0.51) | ITGB3ITGA2BSMYD3GNAI3GNAO1 | |
| SCHEMBL13812236 | 0.85 | ITGB3 (0.46) | ITGB3ITGA2BSMYD3GNAI3GNAO1 | |
| SCHEMBL16083491 | 0.84 | ALDH1A1 (0.53) | ITGB3ITGA2BSMYD3GNAI3GNAO1 | |
| SCHEMBL29765411 | 0.84 | KDM1A (0.48) | ITGB3ITGA2BSMYD3GNAI3GNAO1 | |
| SCHEMBL30364152 | 0.84 | CA2 (0.47) | ITGB3ITGA2BSMYD3GNAI3GNAO1 | |
| SCHEMBL24026487 | 0.83 | ITGB3 (0.46) | ITGB3ITGA2BSMYD3GNAI3GNAO1 | |
| SCHEMBL19884747 | 0.83 | GNAI3 (0.54) | ITGB3ITGA2BSMYD3GNAI3GNAO1 | |
| SCHEMBL16207650 | 0.81 | DDB1 (0.53) | ITGB3ITGA2BSMYD3GNAI3GNAO1 | |
| SCHEMBL4191524 | 0.81 | SMYD3 (0.45) | ITGB3ITGA2BSMYD3GNAI3GNAO1 | |
| SCHEMBL3995226 | 0.81 | NAMPT (0.45) | ITGB3ITGA2BSMYD3GNAI3GNAO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1400511-B1 | Methods of producing n-alkoxycarbonylpiperidine derivatives and intermediates therefor | YUKI GOSEI YAKUHIN KOGYO KK (JP) | 2008-09-03 | — | — | EP | claimed |
| US-6900326-B2 | Method of producing N-alkoxycarbonylpiperidine derivative, new compound as raw material therefor, and method of producing the compound | YUKI GOSEI KOGYO CO., LTD. (JP) | 2005-05-31 | — | — | US | claimed |
| US-20040063953-A1 | Method of producing N-alkoxycarbonylpiperidine derivative, new compound as raw material therefor, and method of producing the compound | YUKI GOSEI KOGYO CO., LTD. (JP) | 2004-04-01 | — | — | US | claimed |
| EP-1400511-A1 | Methods of producing n-alkoxycarbonylpiperidine derivatives and intermediates therefor | YUKI GOSEI KOGYO CO., LTD. (JP) | 2004-03-24 | — | — | EP | claimed |
| CN-111868030-B | 1- (1-Tert-butoxycarbonyl-4-piperidylacetyl) -4-methanesulfonyloxy piperidine and preparation method thereof | 有机合成药品工业株式会社 | 2024-07-19 | — | — | CN | disclosed |
| US-11827603-B2 | Method for preparing 1-(1-tert-butoxycarbonyl-4-piperidylacetyl)-4-mesyloxypiperidine and 1-(1-tert-butoxycarbonyl-4-piperidylacetyl)-4-mesyloxypiperidine | YUKI GOSEI KOGYO CO., LTD. (JP) | 2023-11-28 | — | — | US | disclosed |
| US-20220388959-A1 | METHOD FOR PRODUCING 1-(1-TERT-BUTOXYCARBONYL-4-PIPERIDYLACETYL)-4- MESYLOXYPIPERIDINE AND 1-(1-TERT-BUTOXYCARBONYL-4-PIPERIDYLACETYL)-4-MESYLOXYPIPERIDINE | YUKI GOSEI KOGYO CO., LTD. (JP) | 2022-12-08 | — | — | US | disclosed |
| EP-3741743-A1 | METHOD FOR PRODUCING 1-(1-TERT-BUTOXYCARBONYL-4-PIPERIDYLACETYL)-4-MESYLOXYPIPERIDINE AND 1-(1-TERT-BUTOXYCARBONYL-4-PIPERIDYLACETYL)-4-MESYLOXYPIPERIDINE | Yuki Gosei Kogyo Co., Ltd. (JP) | 2020-11-25 | — | — | EP | disclosed |
| CN-111868030-A | Preparation method of 1- (1-tert-butyloxycarbonyl-4-piperidylacetyl) -4-methylsulfonyloxypiperidine and 1- (1-tert-butyloxycarbonyl-4-piperidylacetyl) -4-methylsulfonyloxypiperidine | 有机合成药品工业株式会社 | 2020-10-30 | — | — | CN | disclosed |
| WO-2019142901-A1 | METHOD FOR PRODUCING 1-(1-TERT-BUTOXYCARBONYL-4-PIPERIDYLACETYL)-4-MESYLOXYPIPERIDINE AND 1-(1-TERT-BUTOXYCARBONYL-4-PIPERIDYLACETYL)-4-MESYLOXYPIPERIDINE | 有機合成薬品工業株式会社 | 2019-07-25 | — | — | WO | disclosed |
| EP-1400511-B1 | Methods of producing n-alkoxycarbonylpiperidine derivatives and intermediates therefor | YUKI GOSEI YAKUHIN KOGYO KK (JP) | 2008-09-03 | — | — | EP | disclosed |
| EP-1400511-B1 | Methods of producing n-alkoxycarbonylpiperidine derivatives and intermediates therefor | YUKI GOSEI YAKUHIN KOGYO KK (JP) | 2008-09-03 | — | — | EP | disclosed |
| US-6900326-B2 | Method of producing N-alkoxycarbonylpiperidine derivative, new compound as raw material therefor, and method of producing the compound | YUKI GOSEI KOGYO CO., LTD. (JP) | 2005-05-31 | — | — | US | disclosed |
| US-20040063953-A1 | Method of producing N-alkoxycarbonylpiperidine derivative, new compound as raw material therefor, and method of producing the compound | YUKI GOSEI KOGYO CO., LTD. (JP) | 2004-04-01 | — | — | US | disclosed |
| EP-1400511-A1 | Methods of producing n-alkoxycarbonylpiperidine derivatives and intermediates therefor | YUKI GOSEI KOGYO CO., LTD. (JP) | 2004-03-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11827603-B2 | Method for preparing 1-(1-tert-butoxycarbonyl-4-piperidylacetyl)-4-mesyloxypiperidine and 1-(1-tert-butoxycarbonyl-4-piperidylacetyl)-4-mesyloxypiperidine | AP2A1, TERT, APEH | ITGB3 3715/4885ITGA2B 3610/4885SMYD3 905/4885 |
| US-20220388959-A1 | METHOD FOR PRODUCING 1-(1-TERT-BUTOXYCARBONYL-4-PIPERIDYLACETYL)-4- MESYLOXYPIPERIDINE AND 1-(1-TERT-BUTOXYCARBONYL-4-PIPERIDYLACETYL)-4-MESYLOXYPIPERIDINE | TERT, APEH, AP2A1 | ITGB3 3563/4885ITGA2B 3585/4885SMYD3 1126/4885 |
| US-20040063953-A1 | Method of producing N-alkoxycarbonylpiperidine derivative, new compound as raw material therefor, and method of producing the compound | ORMDL3, MRPS18A, ACSL3 | ITGB3 2625/4885ITGA2B 2970/4885SMYD3 1591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.